Analyst Price Target is $5.00
▲ +160.42% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Allurion Technologies in the last 3 months. The average price target is $5.00, with a high forecast of $5.00 and a low forecast of $5.00. The average price target represents a 160.42% upside from the last price of $1.92.
Current Consensus is
Buy
The current consensus among 2 contributing investment analysts is to buy stock in Allurion Technologies. This Buy consensus rating has held steady for over two years.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Read More